Skip to content

Replimune Group, Inc.

REPL· NasdaqCore metricsCIK 1737953

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · +1.01%
Market cap
$2.08B
94.8M shares
Filings
663
$0.00
Q3 2018
—
-$57.12M
Q2 2027N/M FY26 yoy
-$56.28M
Q2 2027N/M FY26 yoy
-$123.51M
Q2 2027derivedN/M FY26 yoy
-$0.54
Q2 2027N/M FY26 yoy
$307.83M
Q2 2027+88.1% FY26 yoy
$2.08B
—
—
10.2×
-13.66%
—

FY2026 figures · derived

Price

$21.98+140.74%+$12.85past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$221.18MFY 2026
$221.18M0FY 2017FY 2018FY 2019FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
PeriodEndedValueKindSource trail
FY 20262026-03-31$221,184,000reported
FY 20252025-03-31$189,447,000reported
FY 20242024-03-31$174,963,000reported
FY 20232023-03-31$126,527,000reported
FY 20222022-03-31$79,545,000reported
FY 20212021-03-31$56,754,000reported
FY 20192020-03-31$38,761,000reported
FY 20182019-03-31$22,173,000reported
FY 20172018-03-31$13,516,000reported

Segments

Geography
Long-lived assets by Geography, FY2021 to FY2026FY2021United States · FY2021 · $6.87MUnited Kingdom · FY2021 · $576.00KFY2022United States · FY2022 · $6.32MUnited Kingdom · FY2022 · $1.62MFY2023United States · FY2023 · $5.84MUnited Kingdom · FY2023 · $1.64MFY2024United States · FY2024 · $8.99MUnited Kingdom · FY2024 · $1.49MFY2025United States · FY2025 · $12.82MUnited Kingdom · FY2025 · $919.00KFY2026United States · FY2026 · $12.17MUnited Kingdom · FY2026 · $800.00K
LineFY2026ShareChange
United States$12.17M94%−5.0%
United Kingdom$800.00K6.2%−12.9%
Total$12.97M

From the 10-Q filed Oct 28, 2026REPL

Biological products, except diagnostic substances

Replimune Group, Inc. is the 33rd largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Replimune Group, Inc. · CIK 1737953 · Engraved from SEC EDGAR